Apr 12, 2012 | Laboratory Operations, Laboratory Pathology, Management & Operations
Many challenges ahead for Rusckowski because of healthcare’s unfolding transformation Yesterday, after the stock markets closed, Quest Diagnostics Incorporated (NYSE: DGX) issued a press release naming Stephen H. Rusckowski as its new President and CEO. He will assume his duties on May 1, 2012. Quest Diagnostics is the nation’s largest clinical laboratory company. Along with the appointment of its new President and CEO, Quest Diagnostics also announced that Daniel C. Stanzione, Ph.D., would...
